Asia Pacific Cannula Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$32.4

Forecast, 2030 (US$M)

$55.3

CAGR, 2024 - 2030

7.9%

Report Coverage

Asia Pacific

Asia Pacific cannula market, 2018-2030 (US$M)

Related Markets

Asia Pacific cannula market highlights

The Asia Pacific cannula market generated a revenue of USD 32.4 million in 2023.
The market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
In terms of segment, cardiac was the largest revenue generating product in 2023.
Dermatology is the most lucrative product segment registering the fastest growth during the forecast period.
Country-wise, India is expected to register the highest CAGR from 2024 to 2030.

Asia Pacific data book summary

Market revenue in 2023	USD 32.4 million
Market revenue in 2030	USD 55.3 million
Growth rate	7.9% (CAGR from 2023 to 2030)
Largest segment	Cardiac
Fastest growing segment	Dermatology
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Cardiac, Dermatology, Nasal
Key market players worldwide	Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp

Other key industry trends

In terms of revenue, Asia Pacific region accounted for 18.2% of the global cannula market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 55.3 million by 2030.

Cardiac was the largest segment with a revenue share of 46.6% in 2023. Horizon Databook has segmented the Asia Pacific cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.

Asia Pacific is expected to grow at a higher CAGR over the forecast period owing to presence of a large patient pool, high proportion of the elderly suffering from chronic lifestyle diseases such as diabetes & cardiovascular diseases, and favorable government policies to transform healthcare practices in respective countries, especially in rural belts. Increasing prevalence of cardiovascular diseases and diabetes is expected to propel the market growth.

Key Regions: Japan , U.S. , UK , Brazil , UAE